RxDoctor Payments Data

Ryan Gossett, MD

Hospitalist · Weston, WINPI 1710924329

Payments from drug & device makers

$171in general payments, 2019–2025

Across 11 payments — averaging $15.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi Pasteur Inc.$25
  • Novo Nordisk$22
  • Sanofi-aventis U.S. LLC$19
  • Johnson & Johnson$17
  • Lilly USA, LLC$17
  • Nestle Healthcare Nutrition Inc.$16
  • plus $55 from 4 others

What the payments were for

  • Food & beverage$15591%
  • Education$169%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$171 in reported general payments places this provider in the 75th percentile of 679 hospitalist providers in Wisconsin.

See all hospitalist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$47,833
Medicare patients
261
Services billed
647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban291$154,504
JardianceEmpagliflozin74$53,360
Semglee (Yfgn) PenInsulin Glargine-Yfgn43$29,792
TrulicityDulaglutide30$26,024
JanuviaSitagliptin Phosphate26$21,926
OzempicSemaglutide22$19,784
MyrbetriqMirabegron37$18,615
FarxigaDapagliflozin Propanediol23$17,677
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr28$15,069
XareltoRivaroxaban20$13,169
Nurtec OdtRimegepant Sulfate13$11,968
Spiriva RespimatTiotropium Bromide20$10,761
Fluticasone-SalmeterolFluticasone Propion/Salmeterol56$9,775
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,936
Bydureon BciseExenatide Microspheres11$8,796

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet Xr$13$28,96339 claims
Lilly USA, LLCTrulicity$17$26,02430 claims
Novo NordiskOzempic$22$19,78422 claims
Astellas Pharma US IncMyrbetriq$13$18,61537 claims
Johnson & JohnsonXarelto$17$13,16920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 679 hospitalist providers in Wisconsin.

Other hospitalist in Weston

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →